Atrial Fibrillation, Heart Failure, Ischemic Heart Disease, Valvular Heart Disease
Conditions
Brief summary
The MEA cardiology societies have joined forces to tackle the issue by establishing a tangible real-world data registry in every MEA country. This endeavor has resulted in the development of a multicenter registry called MEA-WCVD, which is being sponsored by each national cardiology society from participating countries. All data gathered will be consolidated into a singular registry for thorough analysis. Country specific analysis will be performed.
Interventions
None listed
Sponsors
Tunisian Society of Cardiology and Cardiovascular Surgery
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* All incomers in Cardiovascular (CV) diseases in hospital or out hospital facilities with one of the 4 diagnosis (Heart Failure (HF), Atrial fibrillation (AF), Valvular Heart disease (VHD), ischemic heart disease (IHD) * Age over 18 years old * Men and Women * Signature of consent form
Exclusion criteria
Patients with diseases other than the 4 previously mentioned in inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular diseases care management in women will be compared to men in MEA countries according to current practice guidelines | 2 months |
Secondary
| Measure | Time frame |
|---|---|
| Identify inequalities between both genders in terms of: • Healthcare insurance • Incomes • Access to healthcare | 2 months |
Countries
Tunisia
Contacts
Primary ContactSalem Abdessalem, Dr
Backup ContactSelma Charfeddine, Dr
Outcome results
None listed